458 filings
Page 2 of 23
3
CRXM
Gene Biotherapeutics, Inc.
14 Aug 20
Gene Biotherapeutics / James L Grainer ownership change
1:40pm
3
CRXM
Gene Biotherapeutics, Inc.
8 Jul 20
Gene Biotherapeutics / Kaushik K. Vyas ownership change
12:37pm
3
CRXM
Gene Biotherapeutics, Inc.
8 Jul 20
Gene Biotherapeutics / Ronald J. Shebuski ownership change
12:36pm
3
CRXM
Gene Biotherapeutics, Inc.
1 Jun 20
Initial statement of insider ownership
5:29pm
SC 13D
Nostrum Pharmaceuticals, LLC
1 Jun 20
Gene Biotherapeutics / Nostrum Pharmaceuticals ownership change
5:27pm
8-K
CRXM
Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
CRXM
Gene Biotherapeutics, Inc.
20 Mar 19
Gene Biotherapeutics Announces Director Retirement
6:15am
SC 13D
Rothenburg Barry
22 Jan 19
Beneficial ownership report
10:05am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
4 Dec 18
Notice of late quarterly filing
3:16pm
8-K
CRXM
Gene Biotherapeutics, Inc.
13 Sep 18
Gene Biotherapeutics Announces Sale of Excellagen Technology
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
16 May 18
Notice of late quarterly filing
4:08pm
8-K
CRXM
Gene Biotherapeutics, Inc.
9 Jan 18
Taxus Cardium Announces Name
12:00am
SC 13G/A
Sabby Management, LLC
4 Jan 18
Taxus Cardium Pharmaceuticals Group Inc.
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
15 Nov 17
Notice of late quarterly filing
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
15 Aug 17
Notice of late quarterly filing
12:00am
10-K
2016 FY
CRXM
Gene Biotherapeutics, Inc.
Annual report
28 Jul 17
12:00am
10-Q
2017 Q1
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
28 Jul 17
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
16 May 17
Notice of late quarterly filing
12:00am
NT 10-K
CRXM
Gene Biotherapeutics, Inc.
30 Mar 17
Notice of late annual filing
12:00am
10-Q
2016 Q3
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
21 Mar 17
12:00am